The RHT business model is ripe for rapid growth.
It has the products in place, it has the technology, it has regulatory approvals, it has revenue, it is low cost business to operate, it is now positioned in the global health market, it provides an alternative to a biopsy in the liver diagnostic market, its technology continues to develop, it is flying under the radar
It is not a matter of if it will take off.........its now a matter of when!
Add to My Watchlist
What is My Watchlist?
